Evotec SE

Equities

EVT

DE0005664809

Market Closed - Xetra Other stock markets 09:05:09 13/06/2025 pm IST			5-day change	1st Jan Change
7.398 ^EUR	-2.66%		+4.79%	-9.73%

03/06	Evotec SE Approves Board Appointments	CI
27/05	Evotec corrects recent rise – chart uninspiring	DP

Evotec SE, Nine Months 2023 Earnings Call, Nov 08, 2023

Published on 08/11/2023 at 18:30

Presentation Operator Message
Operator (Operator)

Ladies and gentlemen, thank you for standing by. Welcome, and thank you for joining the Evotec SE Quarterly Statement 9 Months 2023. [Operator

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Evotec SE

Evotec SE Approves Board Appointments	03/06	CI
Evotec corrects recent rise – chart uninspiring	27/05	DP
Evotec recovers to March level	23/05	DP
EVOTEC : RBC reiterates its Buy rating	15/05	ZD
Peptone Establishes Strategic Partnership with Evotec to Selectively Target Intrinsically Disordered Proteins and Advance Small-Molecule Therapeutics at Scale	08/05	CI
EVOTEC : Deutsche Bank gives a Neutral rating	07/05	ZD
Evotec Secures New Grant to Develop Tuberculosis Treatments	07/05	MT
Evotec Receives $2.5 Mln Grant For Tb Treatments	07/05	RE
Evotec SE, Q1 2025 Earnings Call, May 06, 2025	06/05
EVOTEC : Warburg Research keeps its Buy rating	06/05	ZD
Evotec SE Reports Earnings Results for the First Quarter Ended March 31, 2025	06/05	CI
Evotec starts the year with a decline in sales – shares lose significant ground	06/05	DP
RBC leaves Evotec at 'Outperform' - target €11.60	06/05	DP
Evotec very weak after quarterly figures	06/05	DP
EVOTEC : Receives a Buy rating from RBC	06/05	ZD
Evotec Outlook FY Revenue EUR 840-880 Million	06/05	RE
Evotec's Ongoing Bristol Myers Collaboration Triggers $75 Million Payments	24/04	MT
Evotec recovery stalls despite success in research alliance	24/04	DP
Evotec Announces Progress In Protein Degradation Collaboration With Bristol Myers Squibb	24/04	RE
Deutsche Bank Research raises Evotec to 'Hold' and target price to €7	24/04	DP
EVOTEC : Upgraded to Neutral by Deutsche Bank	24/04	ZD
Evotec shares jump – successful research alliance	24/04	DP
Evotec stands to gain $75 million from research alliance with Bristol-Myers Squibb	24/04	DP
Evotec SE Announces Significant Progress in Strategic Protein Degradation Collaboration with Bristol Myers Squibb	24/04	CI
Warburg Research lowers target for Evotec to €12.10 – 'Buy'	23/04	DP